Aktie 923145 USANA HEALTH SCIENCES, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen USANA Health Sciences, Inc.

Aktien

923145

US90328M1071

USNA

Markt geschlossen - Nyse
Andere Börsenplätze
 22:00:02 31.05.2024 		% 5 Tage % 1. Jan.
47,6 USD +1,86 % Intraday Chart für USANA Health Sciences, Inc. +1,91 % -11,19 %
07.05. USANA HEALTH SCIENCES, INC. : DA Davidson gibt neutrale Bewertung ab ZM
01.05. Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
USANA HEALTH SCIENCES, INC. : DA Davidson maintient sa recommandation neutre
Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024
USANA Health Sciences, Inc. Reiterates Consolidated Earnings Guidance for the Fiscal Year 2024
USANA Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024
Usana Health Sciences Insider Sold Shares Worth $539,539, According to a Recent SEC Filing
Usana Health Sciences Insider Sold Shares Worth $257,022, According to a Recent SEC Filing
WeightWatchers shares drop as Oprah Winfrey decides to exit board
Transcript : USANA Health Sciences, Inc., Q4 2023 Earnings Call, Feb 07, 2024
USANA Health Sciences Seeks Acquisition Opportunities
USANA Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 30, 2023
USANA Health Sciences, Inc. Provides Earnings Guidance for the Fiscal Year 2024
USANA Health Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 30, 2023
USANA Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
USANA HEALTH SCIENCES, INC. : DA Davidson neutre sur le dossier
Transcript : USANA Health Sciences, Inc., Q3 2023 Earnings Call, Oct 25, 2023
USANA Health Sciences' Q3 Earnings, Sales Decline; Annual Guidance Revised
USANA Health Sciences, Inc. Revises Earnings Guidance for the Year 2023
USANA Health Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Insider Sell: Usana Health Sciences
Insider Sell: Usana Health Sciences
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 923145 Aktie
  4. Nachrichten USANA Health Sciences, Inc.
  5. Andere Sprachen